No | Age/sex | WBC (× 109/L) | Hb (g/L) | PLT (× 109/L) | BM blasts (%) | Dysplasia (%) | RS | Cytogenetics | Mutations | VAF (%) |
---|---|---|---|---|---|---|---|---|---|---|
1 | 33/F | 1.88 | 89 | 99 | < 5 | < 10 | N | Normal | U2AF1 | 40.43 |
2 | 50/M | 1.49 | 40 | 14 | < 5 | < 10 | N | Normal | ASXL1, BCOR | 34.63 |
3 | 66/M | 8.48 | 113 | 14 | < 5 | < 10 | N | Normal | ASXL1, TET2 | 77.96 |
4 | 35/M | 8.86 | 83 | 45 | < 5 | < 10 | N | Normal | ASXL1, TET2 | 49.51 |
5 | 43/M | 4.43 | 93 | 17 | < 5 | < 10 | N | Normal | BCOR | 51.7 |
6 | 61/F | 1.79 | 79 | 88 | < 5 | < 10 | N | Normal | TET2 | 10.79 |
7 | 74/M | 3.3 | 96 | 70 | < 5 | < 10 | N | 20q- | TET2 | 23.96 |
8 | 73/F | 2.35 | 57 | 291 | < 5 | < 10 | N | TET2 | 5.75 | |
9 | 68/F | 1.2 | 67 | 25 | < 5 | < 10 | N | Normal | TP53 | 32.17 |
10 | 50/F | 7.55 | 91 | 25 | < 5 | < 10 | N | 20q- | U2AF1 | 13.86 |
11 | 77/M | 4.22 | 96 | 18 | < 5 | < 10 | N | SRSF2, TET2 | 40.2 | |
12 | 74/M | 2.32 | 51 | 73 | < 5 | < 10 | N | 20q- | SF3B1 | 41.2 |
13 | 48/M | 1.43 | 53 | 32 | < 5 | < 10 | N | Normal | U2AF1 | 43.8 |
14 | 78/M | 8.06 | 67 | 23 | < 5 | < 10 | N | Normal | ZRSR2, BCOR, ASXL1, SRSF2 | 94.6 |
15 | 66/F | 2.08 | 104 | 188 | < 5 | < 10 | N | Normal | BCOR, DNMT3A, IDH1 | 29 |
16 | 54/M | 1.71 | 55 | 380 | < 5 | < 10 | N | Normal | U2AF1, TET2 | 18.5 |